carnitine has been researched along with Cardiac Remodeling, Ventricular in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-carnitine (LC) is considered to have good therapeutic potential for myocardial infarction (MI), but its mechanism has not been clarified." | 8.12 | L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal Pathway. ( Kou, JJ; Li, HR; Liu, Y; Pang, XB; Shi, JZ; Tian, JH; Xie, XM; Yan, Y; Zheng, XM, 2022) |
| "In symptomatic patients with severe aortic stenosis undergoing transcatheter aortic valve replacement, circulating levels of long-chain acylcarnitines were independently associated with measures of maladaptive LV remodeling, and metabolic perturbations lessened after procedure completion." | 7.88 | Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. ( Elmariah, S; Farrell, LA; Furman, D; Gerszten, RE; Lindman, BR; Morningstar, JE; Rhee, EP; Shi, X, 2018) |
| "Perfluorooctanoic acid (PFOA), a wide spread environmental pollutant, was associated with developmental cardiotoxicity in chicken embryo, while the underlying molecular mechanism had not been fully elucidated." | 7.88 | The roles of bone morphogenetic protein 2 in perfluorooctanoic acid induced developmental cardiotoxicity and l-carnitine mediated protection. ( Cui, L; Han, Y; Jiang, Q; Lv, N; Wang, C; Zhao, M; Zhong, W, 2018) |
| "To observe the preventive and therapeutic effects of L-carnitine on the metabolic disorder and cardiac remodeling in alcoholic cardiomyopathy." | 7.74 | [L-carnitine and cardiac metabolism and remodeling indices in alcoholic cardiomyopathy]. ( Jing, L; Li, WM; Song, J; Zhou, LJ, 2008) |
| " The results of the multicenter, randomized, double-blind Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial suggest that the early and long-term administration of L-carnitine attenuates progressive left ventricular dilatation after acute anterior MI." | 6.41 | Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico. ( Colonna, P; Iliceto, S, 2000) |
| "L-carnitine (LC) is considered to have good therapeutic potential for myocardial infarction (MI), but its mechanism has not been clarified." | 4.12 | L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal Pathway. ( Kou, JJ; Li, HR; Liu, Y; Pang, XB; Shi, JZ; Tian, JH; Xie, XM; Yan, Y; Zheng, XM, 2022) |
| "In symptomatic patients with severe aortic stenosis undergoing transcatheter aortic valve replacement, circulating levels of long-chain acylcarnitines were independently associated with measures of maladaptive LV remodeling, and metabolic perturbations lessened after procedure completion." | 3.88 | Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. ( Elmariah, S; Farrell, LA; Furman, D; Gerszten, RE; Lindman, BR; Morningstar, JE; Rhee, EP; Shi, X, 2018) |
| "Perfluorooctanoic acid (PFOA), a wide spread environmental pollutant, was associated with developmental cardiotoxicity in chicken embryo, while the underlying molecular mechanism had not been fully elucidated." | 3.88 | The roles of bone morphogenetic protein 2 in perfluorooctanoic acid induced developmental cardiotoxicity and l-carnitine mediated protection. ( Cui, L; Han, Y; Jiang, Q; Lv, N; Wang, C; Zhao, M; Zhong, W, 2018) |
| ") and 1% NaCl in drinking water for 28 days developed cardiovascular remodelling shown as systolic hypertension, left ventricular hypertrophy, increased thoracic aortic and left ventricular wall thickness, increased left ventricular inflammatory cell infiltration together with increased interstitial collagen and increased passive diastolic stiffness and vascular dysfunction with increased plasma malondialdehyde concentrations." | 3.76 | L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. ( Brown, L; Chunduri, P; Iyer, A; O'Brien, D, 2010) |
| "To observe the preventive and therapeutic effects of L-carnitine on the metabolic disorder and cardiac remodeling in alcoholic cardiomyopathy." | 3.74 | [L-carnitine and cardiac metabolism and remodeling indices in alcoholic cardiomyopathy]. ( Jing, L; Li, WM; Song, J; Zhou, LJ, 2008) |
| "L-carnitine is a necessary nutrient for the transport of fatty acids that are required for generating energy." | 2.84 | Effect of L-Carnitine Supplementation on Reverse Remodeling in Patients with Ischemic Heart Disease Undergoing Coronary Artery Bypass Grafting: A Randomized, Placebo-Controlled Trial. ( Boaventura, G; Colafranceschi, A; Costa, B; D'Ippolito, JA; da Costa, C; da Silva Guimarães, S; da Silva, G; da Silva, L; de Carvalho, M; de Souza Cruz, W; Huguenin, AB; Maciel, G; Scalco, F, 2017) |
| " The results of the multicenter, randomized, double-blind Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial suggest that the early and long-term administration of L-carnitine attenuates progressive left ventricular dilatation after acute anterior MI." | 2.41 | Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico. ( Colonna, P; Iliceto, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, D | 1 |
| Wang, L | 1 |
| Xu, C | 1 |
| Yue, L | 1 |
| Zhang, J | 1 |
| Hao, J | 1 |
| Li, HR | 1 |
| Zheng, XM | 1 |
| Liu, Y | 1 |
| Tian, JH | 1 |
| Kou, JJ | 1 |
| Shi, JZ | 1 |
| Pang, XB | 1 |
| Xie, XM | 1 |
| Yan, Y | 1 |
| da Silva Guimarães, S | 1 |
| de Souza Cruz, W | 1 |
| da Silva, L | 1 |
| Maciel, G | 1 |
| Huguenin, AB | 1 |
| de Carvalho, M | 1 |
| Costa, B | 1 |
| da Silva, G | 1 |
| da Costa, C | 1 |
| D'Ippolito, JA | 1 |
| Colafranceschi, A | 1 |
| Scalco, F | 1 |
| Boaventura, G | 1 |
| Elmariah, S | 1 |
| Farrell, LA | 1 |
| Furman, D | 1 |
| Lindman, BR | 1 |
| Shi, X | 1 |
| Morningstar, JE | 1 |
| Rhee, EP | 1 |
| Gerszten, RE | 1 |
| Lv, N | 1 |
| Zhao, M | 1 |
| Han, Y | 1 |
| Cui, L | 1 |
| Zhong, W | 1 |
| Wang, C | 1 |
| Jiang, Q | 1 |
| Voros, G | 1 |
| Ector, J | 1 |
| Garweg, C | 1 |
| Droogne, W | 1 |
| Van Cleemput, J | 1 |
| Peersman, N | 1 |
| Vermeersch, P | 1 |
| Janssens, S | 1 |
| Wang, J | 1 |
| Guo, T | 1 |
| Jing, L | 1 |
| Li, WM | 1 |
| Zhou, LJ | 1 |
| Song, J | 1 |
| O'Brien, D | 1 |
| Chunduri, P | 1 |
| Iyer, A | 1 |
| Brown, L | 1 |
| Kolwicz, SC | 1 |
| Olson, DP | 1 |
| Marney, LC | 1 |
| Garcia-Menendez, L | 1 |
| Synovec, RE | 1 |
| Tian, R | 1 |
| Buziashvili, IuI | 1 |
| Kliuchnikov, IV | 1 |
| Melkonian, AM | 1 |
| Inozemtseva, EV | 1 |
| Kovalenko, OA | 1 |
| Mamaev, KhK | 1 |
| Onnis, E | 1 |
| Iliceto, S | 2 |
| Orlandi, A | 1 |
| Francesconi, A | 1 |
| Ferlosio, A | 1 |
| Di Lascio, A | 1 |
| Marcellini, M | 1 |
| Pisano, C | 1 |
| Spagnoli, LG | 1 |
| Colonna, P | 1 |
4 reviews available for carnitine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Metabolic remodeling in chronic heart failure.
Topics: Adenosine Triphosphate; Carbohydrate Metabolism; Carnitine; Energy Metabolism; Fatty Acids; Fetal He | 2013 |
[Ischemic remodeling of the left ventricle (definition, pathogenesis, diagnosis, medical and surgical correction)].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitor | 2002 |
[An old strategy which comes up again: metabolic therapy of acute myocardial infarction].
Topics: Carnitine; Glucose; Humans; Insulin; Muscle Cells; Myocardial Infarction; Myocardial Ischemia; Potas | 1999 |
Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico.
Topics: Cardiomyopathy, Dilated; Carnitine; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarc | 2000 |
1 trial available for carnitine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effect of L-Carnitine Supplementation on Reverse Remodeling in Patients with Ischemic Heart Disease Undergoing Coronary Artery Bypass Grafting: A Randomized, Placebo-Controlled Trial.
Topics: Aged; Body Mass Index; Carnitine; Coronary Artery Bypass; Dietary Supplements; Female; Follow-Up Stu | 2017 |
9 other studies available for carnitine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effect of L-carnitine on left ventricular remodeling and cardiac function after PCI in patients with acute myocardial infarction.
Topics: Carnitine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Ventricular Function, | 2022 |
L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal Pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carnitine; Disease Models, Animal; Mice; Mice, Inbre | 2022 |
Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
Topics: Aged, 80 and over; Aortic Valve Stenosis; Biomarkers; Carnitine; Choline; Diabetes Complications; Fe | 2018 |
The roles of bone morphogenetic protein 2 in perfluorooctanoic acid induced developmental cardiotoxicity and l-carnitine mediated protection.
Topics: Animals; Bone Morphogenetic Protein 2; Caprylates; Cardiotoxicity; Carnitine; Chick Embryo; Cytoprot | 2018 |
Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
Topics: 3-Hydroxybutyric Acid; Adaptation, Physiological; Aged; Aged, 80 and over; Aortic Valve Stenosis; Bi | 2018 |
[L-carnitine and cardiac metabolism and remodeling indices in alcoholic cardiomyopathy].
Topics: Animals; Cardiomyopathy, Alcoholic; Carnitine; Male; Myocardium; Rats; Rats, Wistar; Ventricular Rem | 2008 |
L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Carnitine; Desoxycorticosterone; Endothelium, Vascular; Hy | 2010 |
Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy.
Topics: Acetyl-CoA Carboxylase; Animals; Aorta; Blotting, Western; Cardiomegaly; Carnitine; Constriction, Pa | 2012 |
Propionyl-L-carnitine prevents age-related myocardial remodeling in the rabbit.
Topics: Aging; Animals; Cardiotonic Agents; Carnitine; Collagen; Collagen Type I; Disease Models, Animal; En | 2007 |